97590689

Information

• Trademark
• 97590689

• Source

• Serial Number

  97590689

• International Classifications

  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  September 14, 2022
  2 years ago

• Transaction Date

  December 12, 2024
  2 days ago

• Status Date

  June 05, 2024
  6 months ago

• Published for Opposition Date

  October 17, 2023
  a year ago

• Location Date

  December 12, 2023
  a year ago

• Status Code

  730

• Current Location

  INTENT TO USE SECTION

  Employee Name

  STEINPFAD, SARAH

• Attorney Docket Number

  084193.00002

  Attorney Name

  John Gary Maynard, III

  Law Office Assigned Location Code

  N20

• Owners

  • Evolve BioSystems Inc.

Case File Statements

• DM0000: The mark consists of six circles.
• CC0000: Color is not claimed as a feature of the mark.
• GS0421: Developing microbiome preparations for foods and medicines for use by mother and infant pairs; developing microbiome preparations for use in treating patients with atopic, allergic, inflammation, inflammatory conditions, infections, autoimmune, cognitive, metabolic disorders and diseases; development of microbiome preparations for pregnant women; development of microbiome preparations for the prevention and treatment of autism; development of microbiome preparations for older adults, elderly; Pharmaceutical and non-pharmaceutical product research and development; product research and development of medicines, nutritional and dietary supplements; Development of computer platforms technology for discovery and development of therapeutics for the treatment, prevention, palliation, and diagnosis of diseases; Research and development of products for the diagnosis of human disease or human health-related conditions; Research of non-pharmaceutical and pharmaceutical products for the prevention or treatment of human diseases or human health-related conditions; Development of computer platforms for discovery and development of research for therapeutics products for the reduction of risk, diagnosis, prevention, palliation, or treatment of human diseases or human health-related conditions; Medical and scientific research in the field(s) of infant gut microbiome health, maternal-infant health and wellness, infant health and wellness, preterm infant health and wellness; Research and development in the field(s) of maternal health, infant health, preterm infant health, gut health, immune health, namely, vaccine efficiency, and metabolic health; Biomedical research services related to health and clinical status of pregnant women, preterm infants, term infants, toddlers and children; Research and development of diagnostics for biological, behavioral, auditory, and pictorial health indicators; Medical and bioscience research services in the areas of the microbiome, immune system, metabolic systems of pregnant women, preterm infants, term infants, toddlers and children; Medical and bioscience research services in to the areas of the microbiome, immune system, and metabolic systems of older adults and elderly; Platform as a service (PAAS) featuring predictive, monitoring and diagnostic computer software platforms for caregivers and healthcare providers to monitor health and wellness of pregnant women, nursing mothers, caregivers, and their infants; development of consumer devices for recording and monitoring health attributes to work in conjunction with or related to live bacterial therapeutics or food products; Development of tools for measuring and tracking infant health data for purposes of evaluating effectiveness of treatment of diseases and medical conditions; Development of maternal and infant wellness tests and applications; Development of Software as a Medical Device (SaMD); Development of Machine Learning as a Medical Device (MLaMD); Development of downloadable mobile applications for monitoring, managing, and treating medical conditions and diseases

Case File Event Statements

• 9/17/2022 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 9/29/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 9/30/2022 - 2 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 12/7/2022 - 2 years ago

  4 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN

• 2/17/2023 - a year ago

  5 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 2/17/2023 - a year ago

  6 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 2/17/2023 - a year ago

  7 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 6/8/2023 - a year ago

  8 - ASSIGNED TO EXAMINER Type: DOCK

• 6/8/2023 - a year ago

  9 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/8/2023 - a year ago

  10 - NON-FINAL ACTION E-MAILED Type: GNRT

• 6/8/2023 - a year ago

  11 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 9/8/2023 - a year ago

  12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 9/8/2023 - a year ago

  13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 9/8/2023 - a year ago

  14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 9/9/2023 - a year ago

  15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 9/27/2023 - a year ago

  16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 10/17/2023 - a year ago

  17 - PUBLISHED FOR OPPOSITION Type: PUBO

• 10/17/2023 - a year ago

  18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 12/12/2023 - a year ago

  19 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 6/5/2024 - 6 months ago

  20 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 6/5/2024 - 6 months ago

  21 - SOU EXTENSION 1 FILED Type: EXT1

• 6/5/2024 - 6 months ago

  22 - SOU EXTENSION 1 GRANTED Type: EX1G

• 6/13/2024 - 6 months ago

  23 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 12/12/2024 - 2 days ago

  25 - TEAS STATEMENT OF USE RECEIVED Type: EISU

• 12/12/2024 - 2 days ago

  24 - SOU TEAS EXTENSION RECEIVED Type: EEXT